Bromo-Dragonfly — not your father’s hallucinogen
January 8, 2010, 7:08 pm
DELAYED ONSET OF SEIZURES AND TOXICITY ASSOCIATED WITH RECREATIONAL USE OF BROMO-DRAGONFLY Wood DM et al. J Med Toxicol Dec 2009;5:226229.
Bromo-dragonfly is a research chemical first synthesized in 1998 that is occasionally used as a recreational psychedelic agent. It is related to the phenethylamine and acts as a serotonin agonist. It got its name because of its structure which — if one turns ones head and squints — looks somewhat like what as a youth I used to call the “darning needle“. Although not much is known about the psychopharmacology of this drug, multiple anecdotal reports describe delayed onset of hallucinations and prolonged — often bad — “trips”, sometimes lasting for days:
This case report, from London, describes an 18-year-old male who developed agitation and seizures 8 hours after taking bromo-dragonfly and ketamine. Presence of both drugs was confirmed with gas chroatography/mass spectrometry and thin layer chromatography. The authors argue that the clinical chronology makes it unlikely that the seizures were related to ketamine ingestion.
There have been reports of at least one death related in bromo-dragonfly, as well as vasoconstriction and limb ischemia requiring partial amputation.